UAL
67
-2
CAT
70
-2
NFLX
55
-2
BEN
55
2
USB
51
-2
ROST
51
-3
PCG
83
3
C
60
2
EXC
54
3
NEM
42
-6
OKE
67
2
BA
39
3
EXPD
61
2
WHR
61
2
XRAY
41
3
HSIC
57
6
ABBV
57
6
KSS
59
5
HPQ
63
-7
FLR
59
3
UAL
67
-2
CAT
70
-2
NFLX
55
-2
BEN
55
2
USB
51
-2
ROST
51
-3
PCG
83
3
C
60
2
EXC
54
3
NEM
42
-6
OKE
67
2
BA
39
3
EXPD
61
2
WHR
61
2
XRAY
41
3
HSIC
57
6
ABBV
57
6
KSS
59
5
HPQ
63
-7
FLR
59
3
Financhill
Back

Voyager Therapeutics Quote, Financials, Valuation and Earnings

The Fed Just Cut Rates-Here's Alex Green's $1 Million AI Stock Picks

Watch Alex Green's breakdown and discover the next big AI winners!
Sell
19

VYGR
Voyager Therapeutics

Last Price:
5.85
Seasonality Move:
-11.19%

7 Day Trial

ALL ACCESS PASS

$ 7

The Tech Disruption Wall Street Isn't Talking About...Yet

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Voyager Therapeutics Price Quote

$5.85

Voyager Therapeutics Key Stats

Sell
19
Voyager Therapeutics (VYGR) is a Sell
Day range:
$5.81 - $5.99
52-week range:
$5.71 - $11.72
Dividend yield:
0%
P/E ratio:
1.97
P/S ratio:
2.13
P/B ratio:
0.95%
Volume:
496.1K
Avg. volume:
455.3K
1-year change:
-24.42%
Market cap:
$319M
Revenue:
$250M
EPS:
$0.22

How Much Does Voyager Therapeutics Make?

Is Voyager Therapeutics Growing As A Company?

  • What Is Voyager Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 5.09%
  • What Is Voyager Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Voyager Therapeutics Stock Price Performance

What Is Voyager Therapeutics 52-Week High & Low?

Voyager Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Voyager Therapeutics?

Is Voyager Therapeutics Cash Flow Positive?

  • What Is VYGR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$17.6M
  • What Is Voyager Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $114.2M
  • What Is Voyager Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$263.5M

Voyager Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    VYGR return on invested capital is 3.5%
  • What Is Voyager Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 2.42%
  • What Is VYGR Return On Equity?
    ROE is a measure of profitability and is 3.5%

Voyager Therapeutics Earnings Date & Stock Price

Voyager Therapeutics Competitors

Voyager Therapeutics Dividend Yield

Voyager Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 54.7%
Revenue: 509.48% 210.88%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 17.63
Upside from Last Price: 201.28%

Major Shareholders

  • How many VYGR shares are owned by institutional investors?
    50.5M VYGR shares are owned by institutional investors
  • How many VYGR shares are owned by insiders?
    2.9M VYGR shares are owned by insiders